(Q46625958)

23 December 2017

title

Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients (English)

1 reference

23 December 2017

0 references

8

1 reference

23 December 2017

Jonas Bergquist

9

1 reference

23 December 2017

author name string

A Amirkhani

1

1 reference

23 December 2017

C Rajda

2

1 reference

23 December 2017

B Arvidsson

3

1 reference

23 December 2017

K Bencsik

4

1 reference

23 December 2017

K Boda

5

1 reference

23 December 2017

E Seres

6

1 reference

23 December 2017

K E Markides

7

1 reference

23 December 2017

publication date

1 August 2005

1 reference

23 December 2017

European Journal of Neurology

published in

1 reference

23 December 2017

volume

12

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

625-631

1 reference

23 December 2017

Quantitation of tryptophan, kynurenine and kynurenic acid in human plasma by capillary liquid chromatography-electrospray ionization tandem mass spectrometry

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Immunogenicity of interferon beta: differences among products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Oligodendrocyte killing by quinolinic acid in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

The kynurenine pathway of tryptophan degradation as a drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Axonal pathology in multiple sclerosis: relationship to neurologic disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

Enhanced tryptophan degradation in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2005.01041.X

10.1111/J.1468-1331.2005.01041.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017